1. Home
  2. OVID

OVID

Ovid Therapeutics Inc.

as 04-18-2025 1:41pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Founded: 2014 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: N/A IPO Year: 2017
Target Price: $3.03 AVG Volume (30 days): 459.9K
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.37 EPS Growth: N/A
52 Week Low/High: $0.24 - $3.45 Next Earning Date: 05-13-2025
Revenue: $566,000 Revenue Growth: 44.39%
Revenue Growth (this year): -51.34% Revenue Growth (next year): 36.11%

OVID Daily Stock ML Predictions

Stock Insider Trading Activity of Ovid Therapeutics Inc. (OVID)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Rona Jeffrey A OVID CBFO Feb 26 '25 Sell $0.56 3,902 $2,185.12 67,973
ALEXANDER MARGARET A. OVID President and COO Feb 26 '25 Sell $0.56 5,279 $2,956.24 73,406
ALEXANDER MARGARET A. OVID President and COO Jan 27 '25 Buy $0.73 6,810 $4,971.30 34,935

Share on Social Networks: